Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study.

Cardiovasc Diabetol · 2019 · PMC6900858 · PMID 31815634

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

did not reach statistical significanceP = 0.056so close (0.05 < p ≤ 0.1)

However, consistent with previous reports, all-cause mortality was lower during periods of metformin use (HR 0.75 [0.62–0.93], P = 0.009) in this cohort, as was the hazard of hospitalised HF, although this did not reach statistical significance (HR 0.67 [0.47–1.01], P = 0.056).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.